A unique, local partnership — powered by machine learning algorithms — holds the key to optimizing the way stroke patients are transported to care facilities.
Artificial intelligence-informed tools at UT Health Austin are providing patients and surgeons with highly personalized recommendations for treatment options and their likely outcomes.
Hear from former students as they reflect on their Dell Med experience and how it equipped them for success in residency and beyond.
Dell Med maternal fetal medicine specialist Kenneth Moise, M.D, is leading a study into nipocalimab, a new investigational drug that’s showing promise in treating a rare blood disease in babies. It could help prevent anemia and cut down on the need for blood transfusions during pregnancy, making treatment safer and easier.
The Texas Health Catalyst Roundup and Rodeo presented finalist teams of UT collaborators who participated in the latest Texas Health Catalyst application cycle.